IMV Inc IMVIQ

RE:RE:RE:Barcelona Poster from ESMO app

[Breakthorough1]

It's a bit early I guess. Only 13 patients reached the 56 days first scan (7 of them ovarian patients), and the first scan seems to be too early to appreciate the action in solid tumors (as the previous ovarian examples say). But something seems to me really interesting: "these results expand our clinical dataset into four additional hard-to-treat solid tumor indications, as we continue to explore the broad potential of our targeted T cell therapy in more than 20 solid and hematological tumor types"